China Pharma Holdings Inc. Implements 1-for-10 Reverse Stock Split

China Pharma Holdings Inc. will implement a 1-for-10 reverse stock split on April 15, 2025. The new CUSIP number for the common stock will be 16941T 401. The reverse stock split was authorized by the Board and adopted by stockholders through the Annual Meeting for the fiscal year ended on December 31, 2023. The split will affect all stockholders uniformly and will not alter any stockholder's percentage interest in the Company's outstanding common stock.